Report Detail

Pharma & Healthcare Global (United States, European Union and China) Biopolar Disorder Therapeutics Market Research Report 2019-2025

  • RnM3665288
  • |
  • 13 August, 2019
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics.
Rise in prevalence of bipolar disorder, high unmet medical needs, technological advancement and government initiatives are the key factors accelerating the growth of the bipolar disorder therapeutics market. Increase in investment in research and development and collaboration activities between companies for product development are the other factors likely to propel the bipolar disorder therapeutics market. Additionally, the rise in awareness about the disorder has led to increased understanding among the public. This has led to a rise in the number of individuals seeking medical attention for the treatment of the disorder. Also, strategic alliances formed between vendors help in increased penetration of the drugs in the market and increase market share. However, stringent regulations act as a major restraint of the bipolar disorder therapeutics market. North America dominates the global bipolar disorder therapeutics market due to new product innovation, increased awareness among people about bipolar disease, and rise in prevalence of bipolar disorders.
In 2019, the market size of Biopolar Disorder Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biopolar Disorder Therapeutics.

This report studies the global market size of Biopolar Disorder Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biopolar Disorder Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Allergan
AstraZeneca
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
...

Market Segment by Product Type
Mood Stabilizers
Antipsychotic Drugs
Antidepressant Drugs
Others

Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Biopolar Disorder Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biopolar Disorder Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Biopolar Disorder Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Biopolar Disorder Therapeutics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Mood Stabilizers
      • 1.3.3 Antipsychotic Drugs
      • 1.3.4 Antidepressant Drugs
      • 1.3.5 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Biopolar Disorder Therapeutics Market Share by Application (2019-2025)
      • 1.4.2 Hospital Pharmacies
      • 1.4.3 Retail Pharmacies
      • 1.4.4 Online Pharmacies
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Biopolar Disorder Therapeutics Market Size
      • 2.1.1 Global Biopolar Disorder Therapeutics Revenue 2014-2025
      • 2.1.2 Global Biopolar Disorder Therapeutics Sales 2014-2025
    • 2.2 Biopolar Disorder Therapeutics Growth Rate by Regions
      • 2.2.1 Global Biopolar Disorder Therapeutics Sales by Regions 2014-2019
      • 2.2.2 Global Biopolar Disorder Therapeutics Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Biopolar Disorder Therapeutics Sales by Manufacturers
      • 3.1.1 Biopolar Disorder Therapeutics Sales by Manufacturers 2014-2019
      • 3.1.2 Biopolar Disorder Therapeutics Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Biopolar Disorder Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Biopolar Disorder Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Biopolar Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Biopolar Disorder Therapeutics Price by Manufacturers
    • 3.4 Key Manufacturers Biopolar Disorder Therapeutics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Biopolar Disorder Therapeutics Market
    • 3.6 Key Manufacturers Biopolar Disorder Therapeutics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Mood Stabilizers Sales and Revenue (2014-2019)
      • 4.1.2 Antipsychotic Drugs Sales and Revenue (2014-2019)
      • 4.1.3 Antidepressant Drugs Sales and Revenue (2014-2019)
      • 4.1.4 Others Sales and Revenue (2014-2019)
    • 4.2 Global Biopolar Disorder Therapeutics Sales Market Share by Type
    • 4.3 Global Biopolar Disorder Therapeutics Revenue Market Share by Type
    • 4.4 Biopolar Disorder Therapeutics Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Biopolar Disorder Therapeutics Sales by Application

    6 United States

    • 6.1 United States Biopolar Disorder Therapeutics Breakdown Data by Company
    • 6.2 United States Biopolar Disorder Therapeutics Breakdown Data by Type
    • 6.3 United States Biopolar Disorder Therapeutics Breakdown Data by Application

    7 European Union

    • 7.1 European Union Biopolar Disorder Therapeutics Breakdown Data by Company
    • 7.2 European Union Biopolar Disorder Therapeutics Breakdown Data by Type
    • 7.3 European Union Biopolar Disorder Therapeutics Breakdown Data by Application

    8 China

    • 8.1 China Biopolar Disorder Therapeutics Breakdown Data by Company
    • 8.2 China Biopolar Disorder Therapeutics Breakdown Data by Type
    • 8.3 China Biopolar Disorder Therapeutics Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Biopolar Disorder Therapeutics Breakdown Data by Company
    • 9.2 Rest of World Biopolar Disorder Therapeutics Breakdown Data by Type
    • 9.3 Rest of World Biopolar Disorder Therapeutics Breakdown Data by Application
    • 9.4 Rest of World Biopolar Disorder Therapeutics Breakdown Data by Countries
      • 9.4.1 Rest of World Biopolar Disorder Therapeutics Sales by Countries
      • 9.4.2 Rest of World Biopolar Disorder Therapeutics Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Allergan
      • 10.1.1 Allergan Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Biopolar Disorder Therapeutics
      • 10.1.4 Biopolar Disorder Therapeutics Product Introduction
      • 10.1.5 Allergan Recent Development
    • 10.2 AstraZeneca
      • 10.2.1 AstraZeneca Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Biopolar Disorder Therapeutics
      • 10.2.4 Biopolar Disorder Therapeutics Product Introduction
      • 10.2.5 AstraZeneca Recent Development
    • 10.3 Eli Lilly
      • 10.3.1 Eli Lilly Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Biopolar Disorder Therapeutics
      • 10.3.4 Biopolar Disorder Therapeutics Product Introduction
      • 10.3.5 Eli Lilly Recent Development
    • 10.4 GlaxoSmithKline
      • 10.4.1 GlaxoSmithKline Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Biopolar Disorder Therapeutics
      • 10.4.4 Biopolar Disorder Therapeutics Product Introduction
      • 10.4.5 GlaxoSmithKline Recent Development
    • 10.5 Janssen Pharmaceuticals
      • 10.5.1 Janssen Pharmaceuticals Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Biopolar Disorder Therapeutics
      • 10.5.4 Biopolar Disorder Therapeutics Product Introduction
      • 10.5.5 Janssen Pharmaceuticals Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Biopolar Disorder Therapeutics Sales Channels
      • 11.2.2 Biopolar Disorder Therapeutics Distributors
    • 11.3 Biopolar Disorder Therapeutics Customers

    12 Market Forecast

    • 12.1 Global Biopolar Disorder Therapeutics Sales and Revenue Forecast 2019-2025
    • 12.2 Global Biopolar Disorder Therapeutics Sales Forecast by Type
    • 12.3 Global Biopolar Disorder Therapeutics Sales Forecast by Application
    • 12.4 Biopolar Disorder Therapeutics Forecast by Regions
      • 12.4.1 Global Biopolar Disorder Therapeutics Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Biopolar Disorder Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on BiopolarDisorderTherapeutics. Industry analysis & Market Report on BiopolarDisorderTherapeutics is a syndicated market report, published as Global (United States, European Union and China) Biopolar Disorder Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of BiopolarDisorderTherapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,584.64
      3,876.96
      5,169.28
      3,017.60
      4,526.40
      6,035.20
      510,433.60
      765,650.40
      1,020,867.20
      273,486.40
      410,229.60
      546,972.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report